Skip to main content
Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
500.49
+4.66 (0.94%)
Apr 15, 2025, 4:00 PM EDT - Market closed

Vertex Pharmaceuticals Revenue

In the year 2024, Vertex Pharmaceuticals had annual revenue of $11.02B with 11.66% growth. Vertex Pharmaceuticals had revenue of $2.91B in the quarter ending December 31, 2024, with 15.66% growth.

Revenue (ttm)
$11.02B
Revenue Growth
+11.66%
P/S Ratio
11.71
Revenue / Employee
n/a
Employees
n/a
Market Cap
128.52B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202411.02B1.15B11.66%
Dec 31, 20239.87B938.50M10.51%
Dec 31, 20228.93B1.36B17.91%
Dec 31, 20217.57B1.37B22.06%
Dec 31, 20206.21B2.04B49.08%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
McKesson 344.58B
HCA Healthcare 70.60B
AstraZeneca 54.07B
Novartis AG 51.72B
Sanofi 45.85B
Thermo Fisher Scientific 42.88B
GSK plc 39.28B
Medtronic 33.20B
Revenue Rankings

VRTX News

More News